FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to use of a compound represented by formula I or a pharmaceutically acceptable salt thereof for preparing a medicament for preventing and/or treating type I diabetes, type II diabetes, type III diabetes (Alzheimer's disease) or gestational diabetes. Said medicinal agent is intended for administering a compound represented by formula I or a pharmaceutically acceptable salt thereof in dose of 0.1 to 5 mg/kg a day. Formula I is
Formula I,
wherein A is C5 alkyl, C6 alkyl, C5 alkenyl or C6 alkenyl; R1 denotes H, F or OH; R2 is C5 alkyl, C6 alkyl, C5 alkenyl or C6 alkenyl; R3 is H, F, OH or CH2Ph; R4 represents H, F or OH; Q represents (CH2)mC(O)OH, wherein m represents 1 or 2, CH (CH3)C(O)OH or C(CH3)2C(O)OH. Also disclosed are use of a compound of formula I for preparing a medicament for modulating glucose, insulin and/or triglyceride levels, use of compound with formula I for preparing a drug for increasing insulin secretion, and/or increasing insulin sensitivity, and/or reducing insulin resistance, using the compound of formula I to reduce blood triglycerides.
EFFECT: disclosed are substituted aromatic compounds and pharmaceutical compositions for preventing and treating diabetes.
31 cl, 9 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND TREATING OSTEOPOROSIS | 2015 |
|
RU2709205C2 |
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR SELF-REPAIR AND TISSUE REGENERATION | 2015 |
|
RU2728782C2 |
COMPOUNDS POSSESSING ACIVATING ACTION ON PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SUBTYPES (PPARs), AND METHOD FOR PRODUCING AND USING ABOVE COMPOUNDS | 2011 |
|
RU2546117C2 |
α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE INHIBITORS | 2019 |
|
RU2841136C2 |
INHIBITORS - AMINO - CARBOXYMUCONATE - SEMIALDEHYDE - DECARBOXYLASE | 2015 |
|
RU2746405C2 |
CYTIDINE DERIVATIVES AND METHODS OF PRODUCING CYTIDINE DERIVATIVES | 2020 |
|
RU2828746C2 |
ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
FLUOROPHENYL-BETA-HYDROXYETHYLAMINES AND THEIR USE FOR THE TREATMENT OF HYPERGLYCEMIA | 2018 |
|
RU2801096C2 |
Authors
Dates
2020-06-11—Published
2015-10-08—Filed